Analyst · Elite Pharmaceuticals, Inc. (ELTP) | Ratings, Price Targets & Consensus

Ratings

Updated Aug 21, 2026

Overall Rating

A

DCF Score4.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score3.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$0.30

DCF Value-153.26%

-$0.16

Potential downside vs current price

Current Stock Price

$0.30

DCF Value-153.26%

-$0.16

Potential downside vs current price

Ratings

Updated Aug 21, 2026

Overall Rating

A

DCF Score4.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score3.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$0.30

DCF Value-153.26%

-$0.16

Potential downside vs current price

Current Stock Price

$0.30

DCF Value-153.26%

-$0.16

Potential downside vs current price